Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for autonomic function and postoperative recovery under general anesthesia
ChiCTR2000039331Phase 4Recruiting
- Sponsor
- Yangzhou First People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in dysautonomia, Postoperative gastrointestinal dysfunction (POGD) and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yangzhou First People's Hospital. Primary endpoints: Heart rate variability indicators and Postoperative nausea and vomiting (PONV) score. Started Oct 2020; status: recruiting.
02
Drugs
lidocaine
03
Conditions
dysautonomiaPostoperative gastrointestinal dysfunction (POGD)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2000039331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039331.